title: Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome.
abstract: This study supports the importance of regulatory role of the E(2) in growth hormone secretion in women with polycystic ovary syndrome, showing for the first time a different weight-related sensitivity of the growth-hormone axis to hypoestrogenism induced by gonadotropin-releasing hormone agonist.
authors.forename: Paola
authors.initials: P
authors.lastname: Villa
authors.forename: Laura
authors.initials: L
authors.lastname: De Marinis
authors.forename: Antonio
authors.initials: A
authors.lastname: Mancini
authors.forename: Maurizio
authors.initials: M
authors.lastname: Guido
authors.forename: Luigi
authors.initials: L
authors.lastname: Selvaggi
authors.forename: Antonio
authors.initials: A
authors.lastname: Lanzone
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000378:metabolism*; D017329:Triptorelin Pamoate / Q000494:pharmacology*
chemical_list: D017329:Triptorelin Pamoate; D019382:Human Growth Hormone; D007987:Gonadotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone